302 related articles for article (PubMed ID: 36098029)
21. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
[TBL] [Abstract][Full Text] [Related]
22. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
[TBL] [Abstract][Full Text] [Related]
23. Positioning time in range in diabetes management.
Advani A
Diabetologia; 2020 Feb; 63(2):242-252. PubMed ID: 31701199
[TBL] [Abstract][Full Text] [Related]
24. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
[TBL] [Abstract][Full Text] [Related]
25. Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
Zhong T; He B; Li X; Lei K; Tang R; Zhao B; Li X
Diabetologia; 2024 Jan; 67(1):42-51. PubMed ID: 37889319
[TBL] [Abstract][Full Text] [Related]
26. Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors-East meets west symposium.
Oliver N; Chow E; Luk AOY; Murphy HR
Diabet Med; 2023 May; 40(5):e15038. PubMed ID: 36617376
[TBL] [Abstract][Full Text] [Related]
27. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Yoo JH; Choi MS; Ahn J; Park SW; Kim Y; Hur KY; Jin SM; Kim G; Kim JH
Diabetes Technol Ther; 2020 Oct; 22(10):768-776. PubMed ID: 32167394
[No Abstract] [Full Text] [Related]
28. Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes.
Abdelhafiz AH; Sinclair AJ
J Diabetes Complications; 2022 Apr; 36(4):108144. PubMed ID: 35151546
[TBL] [Abstract][Full Text] [Related]
29. Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Kuroda N; Kusunoki Y; Osugi K; Ohigashi M; Azuma D; Ikeda H; Makino S; Otsuka A; Tamada D; Watanabe N; Washio K; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Koyama H;
J Diabetes Investig; 2021 Feb; 12(2):244-253. PubMed ID: 32594655
[TBL] [Abstract][Full Text] [Related]
30. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
Monnier L; Colette C; Owens D
Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
[TBL] [Abstract][Full Text] [Related]
31. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
[TBL] [Abstract][Full Text] [Related]
32. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
[No Abstract] [Full Text] [Related]
33. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
34. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
Bao S; Bailey R; Calhoun P; Beck RW
Diabetes Technol Ther; 2022 May; 24(5):299-306. PubMed ID: 34939824
[No Abstract] [Full Text] [Related]
36. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.
Sotani-Ogawa R; Kusuhara S; Hirota Y; Kim KW; Matsumiya W; Ogawa W; Nakamura M
Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):449-456. PubMed ID: 37864636
[TBL] [Abstract][Full Text] [Related]
37. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
38. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
[No Abstract] [Full Text] [Related]
39. Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN).
Chao C; Andrade SB; Bergford S; Calhoun P; Welsh JB; Walker TC;
Endocrinol Diabetes Metab; 2023 May; 6(3):e414. PubMed ID: 36864014
[TBL] [Abstract][Full Text] [Related]
40. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes.
Wakasugi S; Mita T; Katakami N; Okada Y; Yoshii H; Osonoi T; Kuribayashi N; Taneda Y; Kojima Y; Gosho M; Shimomura I; Watada H
Cardiovasc Diabetol; 2021 Jan; 20(1):15. PubMed ID: 33413339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
